Title : PERK/ATF4-Dependent ZFAS1 Upregulation Is Associated with Sorafenib Resistance in Hepatocellular Carcinoma Cells.

Pub. Date : 2021 May 29

PMID : 34072570






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PERK/ATF4-Dependent ZFAS1 Upregulation Is Associated with Sorafenib Resistance in Hepatocellular Carcinoma Cells. Sorafenib activating transcription factor 4 Homo sapiens
2 In vitro experimental evidence suggested that sorafenib induced protein kinase RNA-like ER kinase (PERK)/activating transcription factor 4 (ATF4)-dependent ZFAS1 expression, and sorafenib resistance could be overcome by PERK/ATF inhibitors. Sorafenib activating transcription factor 4 Homo sapiens
3 In vitro experimental evidence suggested that sorafenib induced protein kinase RNA-like ER kinase (PERK)/activating transcription factor 4 (ATF4)-dependent ZFAS1 expression, and sorafenib resistance could be overcome by PERK/ATF inhibitors. Sorafenib activating transcription factor 4 Homo sapiens
4 Therefore, PERK/ATF4/ZFAS1 signaling axis might be an attractive therapeutic and prognostic biomarker for sorafenib therapy in HCC. Sorafenib activating transcription factor 4 Homo sapiens